AIM
MYGN icon

Ada Investment Management’s Myriad Genetics MYGN Stock Holding History

Ada Investment Management’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		$247K Sell
5,723
-442
-7% -$18.7K 0.17% 259
2015
Q3 		$252K Buy
+6,165
New +$219K 0.13% 324

Other funds holding MYGN

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Ada Investment Management's MYGN Position: Q4 2015 in Review

Ada Investment Management reduced its Myriad Genetics (MYGN) stake by 7.2% in Q4 2015, selling an estimated $18.7K and leaving 5,723 shares worth $247K. The position accounts for 0.17% of the portfolio, ranked #259.

Ada Investment Management first reported a position in MYGN in Q3 2015 and has held it in 2 quarters since. The position peaked at $252K in Q3 2015. 232 funds tracked by Wall St. Rank hold MYGN as of Q4 2015.

  • Ada Investment Management held 5,723 shares of Myriad Genetics worth $247K as of Q4 2015.
  • Ada Investment Management sold 442 Myriad Genetics shares in Q4 2015, an estimated $18.7K.
  • Myriad Genetics made up 0.17% of Ada Investment Management's portfolio in Q4 2015, its #259 holding.
  • Ada Investment Management first reported a position in Myriad Genetics in Q3 2015 and has held it in 2 quarters since.
  • Ada Investment Management's Myriad Genetics position peaked at $252K in Q3 2015.
  • 232 funds tracked by Wall St. Rank held Myriad Genetics as of Q4 2015.

Based on Ada Investment Management's 13F filing for Q4 2015, filed 19 Feb 2016.